Back
Raymond James Financial Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
72
RJF
Raymond James Financial
Last Price:
169.20
Seasonality Move:
8.58%
Buy
58
SRPT
Sarepta Therapeutics
Last Price:
133.49
Seasonality Move:
14.88%
Buy
72
Raymond James Financial (RJF)
is a Buy
Is Raymond James Financial a Buy, Sell or Hold?
- The current Raymond James Financial [RJF] share price is $169.28. The Score for RJF is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- RJF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RJF Stock Price Chart
What is Raymond James Financial's stock price today?
-
The Raymond James Financial share price today is $169.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RJF is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
RJF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.22 | Buy |
| Relative Strength Index (14 RSI): | 75.36 | Buy |
| Chaikin Money Flow: | -385408 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (149.76 - 166.28) | Buy |
| Bollinger Bands (100): | (111.1 - 147.96) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 63.54 | Buy |
| Chaikin Money Flow: | -725343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.85 - 129.81) | Buy |
| Bollinger Bands (100): | (119.21 - 141.67) | Buy |
RJF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.14 | Buy |
| 20-day SMA: | 160.55 | Buy |
| 50-day SMA: | 143.69 | Buy |
| 200-day SMA: | 126.02 | Buy |
| 8-day EMA: | 166.56 | Buy |
| 20-day EMA: | 160.39 | Buy |
| 50-day EMA: | 147.6 | Buy |
| 200-day EMA: | 127.77 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 119.83 | Buy |
| 20-day SMA: | 118.14 | Buy |
| 50-day SMA: | 122.33 | Buy |
| 200-day SMA: | 130.09 | Buy |
| 8-day EMA: | 123.82 | Buy |
| 20-day EMA: | 120.48 | Buy |
| 50-day EMA: | 122.96 | Buy |
| 200-day EMA: | 126.17 | Buy |
Raymond James Financial Earnings Growth & RJF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $0.92 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Raymond James Financial Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||